Feline Hepatic Lipidosis: Feeding and Refeeding Risk

Bottom line

Feline hepatic lipidosis requires nutritional intervention and investigation of the disease or circumstance that stopped eating. Concurrent disease changes treatment and prognosis. [1] Appetite medication should not delay feeding-tube placement when intake remains inadequate. [2]

Establish what lipidosis explains

Ultrasound can support a presumptive diagnosis and identify concurrent abdominal disease. Hepatic cytology may show lipid-laden hepatocytes but miss localized or multifocal infiltrative lesions. Nondiagnostic or atypical cytology and abnormal imaging can justify further tissue investigation. [1]

Document whether lipidosis is the working diagnosis, cytologically supported, or accompanied by another demonstrated condition. Use the feline icterus workup for the broader hemolysis, hepatic, and obstructive differential. Here the immediate decision is how to deliver nutrition safely while that workup continues.

Build the feeding plan before more fasting accumulates

Assess weight, muscle and body condition, dietary history, actual intake, and time already spent anorectic at home. The ISFM guideline recommends correcting dehydration and major electrolyte or acid-base disturbances and achieving cardiovascular stability before feeding. Enteral support is preferred in most cases when tolerated. [2]

Select tube route around expected support duration, anesthesia risk, diet consistency, and caregiver capacity. Write down the daily prescription, what was actually delivered, water and flush contributions, tolerance, and voluntary intake. An intended calorie target is not evidence that the cat received it.

The transdermal mirtazapine reference covers the separate medication evidence. Measure the eating response rather than assuming appetite stimulation has corrected the nutritional deficit.

Refeeding is an evolving metabolic assessment

Refeeding syndrome is not limited to a low phosphate result. A retrospective series of starved cats documented potassium and glucose disturbances, anemia, neurological abnormalities, and kidney injury alongside phosphate changes. Most had been missing and presumed starved; it was not a hepatic-lipidosis-only cohort. [3]

This supports a broader monitoring discussion, not a lipidosis-specific event rate. Obtain baseline values, arrange serial electrolyte and glucose measurements, and reassess weakness, mentation, hydration, and cardiorespiratory status as feeding advances. Individualize the pace and supplementation to risk and evolving results rather than using rapid replacement of lost body weight as the initial goal.

Webb's lipidosis review specifically describes hypophosphatemia with hemolysis associated with initiation of enteral nutrition. [1] New anemia during recovery warrants investigation rather than attribution to the original liver disease alone.

Tube complications need a response plan

A retrospective referral study of sick cats found tube complications were mostly mild and manageable. Its heterogeneous disease population and nonrandomized tube selection do not establish that one route is superior for lipidosis. [4]

The ISFM guideline advises stopping feeding immediately if gagging, coughing, retching, vocalization, or struggling occurs and checking for tube dislodgement. Tube-site care and accounting for feeding and flushing water are part of monitoring. [2]

Before discharge, have the caregiver demonstrate preparation, administration, flushing, and site inspection. Specify whom to contact if the tube moves, blocks, leaks, or the cat becomes distressed. Demonstration and written instructions should describe the actual tube and diet, not a generic handout alone.

Reassess the disease as well as the calories

Review nutritional delivery, tolerance, body and muscle condition, laboratory trends, and the concurrent-disease plan together. Document whether spontaneous intake is nutritionally adequate before reducing assisted support. A few bites and a prescribed ration are different clinical observations.

Failure to progress should reopen questions about feed delivery, metabolic complications, and the primary cause of anorexia. Agree on explicit follow-up responsibilities between the hospital, primary clinician, and caregiver.

Frequently Asked Questions

Does hepatic lipidosis exclude another primary disease?

No. Concurrent disease can cause the anorexia and changes treatment and prognosis. [1]

Can hepatic cytology miss other disease?

Yes. Localized or multifocal infiltrative lesions may be missed, and atypical or nondiagnostic findings can require further investigation. [1]

Should appetite medication postpone assisted nutrition?

No. ISFM states that feeding-tube placement should not be delayed while appetite medications are used. [2]

What should be corrected before feeding starts?

The guideline recommends addressing dehydration and major electrolyte or acid-base abnormalities and establishing cardiovascular stability. [2]

Is refeeding syndrome only hypophosphatemia?

No. A starved-cat case series also documented potassium and glucose disturbances and systemic complications. It was not specific to hepatic lipidosis. [3]

Does the feeding-tube cohort prove one route is best?

No. It was a retrospective, heterogeneous referral population with nonrandomized tube selection. [4]

What should happen if a cat coughs or struggles during tube feeding?

Stop feeding immediately and check for dislodgement, as advised by ISFM. [2]